Clinical Trials Directory

Trials / Completed

CompletedNCT06037382

Using a Smartphone App to Target Current Mental Health Symptoms of Anxiety and Depression

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
102 (actual)
Sponsor
Trustees of Dartmouth College · Academic / Other
Sex
All
Age
40 Years – 64 Years
Healthy volunteers
Not accepted

Summary

This is a prevention intervention study that will examine the efficacy of a smartphone-based intervention in decreasing cancer risk by targeting mental health risk factors of anxiety and depression.

Detailed description

This prevention intervention study aims to examine the efficacy of a smartphone-based intervention in decreasing cancer risk by targeting mental health risk factors of anxiety and depression. The study will utilize a smartphone application called Mood Triggers, designed to provide personalized feedback on individuals' maintenance factors (i.e., "triggers") of their anxiety and depressive symptoms. Mood Triggers delivers ultra-brief interventions (less than 2 minutes long) where participants view videos introducing important skills to treat their anxiety and depression. The study targets middle-aged adults (40-64 years old) who meet current criteria for moderate to severe anxiety and/or depressive disorders. It will enroll an anticipated 100 participants in a single-group, open-label design, with the intervention lasting up to 12 weeks. The primary outcomes include changes in depression and anxiety symptoms, measured by the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder-Q-IV Scale, respectively, as well as changes in cancer risk assessed by the World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Score.

Conditions

Interventions

TypeNameDescription
OTHERMood Triggers AppThe current intervention will deploy a smartphone application called Mood Triggers. Mood Triggers was designed to provide personalized feedback on individuals' maintenance factors (i.e., "triggers") of their anxiety and depressive symptoms based on the theory that such feedback will lead to symptom reduction.

Timeline

Start date
2023-09-25
Primary completion
2025-03-06
Completion
2025-03-06
First posted
2023-09-14
Last updated
2025-03-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06037382. Inclusion in this directory is not an endorsement.